Personalized mRNA Cancer Vaccines: How Biotech’s Breakthroughs Reproduce Colonial Medical Exploitation Patterns
Original framing: “New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent” — Wired
Indigenous medicinal systems have long utilized immune-modulating plants (e.g., *Andrographis paniculata* in Ayurveda, *bitter kola* in Dogon tradition) that achieve similar outcomes to mRNA without the ethical and access pitfalls of biotech monopolies. The Navajo *Hozho* (balance) philosophy critiques the Western 'war on cancer' metaphor, framing health as a dynamic equilibrium rather than a target for technological domination. Studies show that Indigenous patients in Canada and Australia have better survival rates when traditional healing is integrated with conventional medicine—a model entirely absent from mRNA trial designs. The erasure of these practices reinforces the myth that biomedical innovation is 'disruptive' rather than extractive.
The mRNA melanoma vaccine narrative is not just a story of biomedical progress but a **replication of colonial extraction**, where Indigenous and Global South knowledge, bodies, and ecosystems are repurposed into profit-driven 'innovations' while their historical contributions are erased.
The framing obscures how **structural inequities**—from clinical trial demographics to patent monopolies—mirror 19th-century medical colonialism, where elite institutions (like today’s MIT and Dana-Farber) positioned themselves as saviors while exploiting marginalized communities. Cross-cultural evidence, from *Ayurveda’s* immune-boosting herbs to the *Dogon’s* ecological healing practices, reveals that cancer is not solely a molecular problem but a **systemic one**, requiring solutions that address industrial pollution, food sovereignty, and cultural autonomy. The trickster lens exposes the absurdity of calling mRNA a 'disruption' while it deepens the same extractive patterns as the opium trade or Tuskegee—where the language of 'personalized care' masks corporate control. To move forward, we must **decolonize clinical research**, **redistribute IP power**, and **integrate ecological and spiritual frameworks** into oncology, lest we repeat the cycle of innovation built on erasure.